Monday, 18 May 2020

Stroke Disorder and Treatment Market Overview with Detailed Analysis, Competitive landscape, Forecast to 2022

Heart problems and brain problems are considered among most dangerous medical problems, and their treatments are considered to be most expensive. Heart strokes and brain strokes can strike any moment and can be fatal. Hence, the market offering treatment for it is always lucrative. Globally it is increasing rapidly. The major factor that drives the growth of this market is the increasing high blood pressure patients. Due to increasing alcoholism and patients with diabetes, cardiovascular diseases are increasing the growth of this disorder and the market offering its treatment.
Market Research Future (MRFR) has published a research report about the global stroke disorder and treatment market that estimates huge aggrandizement in this market between 2016 and 2022. This report provides a detailed analysis of the market structure along with a forecast for the next seven years. It analyzes the market on the basis of various factors including porters five force analysis, price analysis, and supply chain analysis. Providing insights about the current market size and future prospects, this report features expert opinions. Profiling the key players in the market, this report covers competitive developments such as joint ventures, mergers and acquisitions, new product developments, strategic alliances, and research and developments in the global market.
The global stroke disorder and treatment market has been segmented into medicines, treatment, types, and lastly region. On the basis of medicines, this market has been segmented into anticoagulants, anti-hypertensive, and antiplatelet. Anticoagulants, also called blood thinners, are chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time. Apixaban (Eliquis), dabigatran (Pradaxa), edoxaban (Savaysa), enoxaparin (Lovenox), fondaparinux (Arixtra), heparin, rivaroxaban (Xarelto), and warfarin (Coumadin) are some examples of anticoagulants. Antiplatelet is a member of a class of pharmaceutical drugs that decrease platelet aggregation and inhibit thrombus formation. They are more effective in the arterial circulation compared anticoagulants. Examples of antiplatelet include clopidogrel (Plavix), dipyridamole/aspirin (Aggrenox), eptifibatide (Integrilin), prasugrel (Effient), ticagrelor (Brilinta), and ticlodipine (Ticlid). Antihypertensives are a class of drugs that are used to treat hypertension (high blood pressure). Examples of antihypertensives include benazepril (Lotensin), captopril (Capoten), enalapril (Vasotec), lisinopril (Zestril and Prinivil), perindopril (Aceon), quinapril (Accupril), ramipril (Altace), and trandolapril (Mavik).  
Treatment-based segmentation of the market covers tissue plasminogen activator (TPA) and endovascular procedures. TPA is an enzyme involved in the breakdown of blood clots and dissolves them. The endovascular procedure is surgery. Being innovative, it is a less invasive procedure, popularly used for treating problems affecting the blood vessels, such as an aneurysm, which is a swelling or “ballooning” of the blood vessel. By types, the market has been segmented into hemorrhagic strokes and ischemic stroke. The weakened blood vessel leakage is called a hemorrhagic stroke. Its two categories are aneurysms and arteriovenous malformations. Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain.
The regional segmentation of global stroke disorder and treatment market cover North America, Europe, and the Asia Pacific. The key players of this market are primarily based in these continents. In other parts of the world, the market for stroke disorder and treatment is limited due to less advanced medical facilities, little investment in health care, lack of awareness about stroke disorder, and poor infrastructure. In North America and Europe, investments in research and development (R & D) and advanced medical facilities boost this market. According to this report, the market in North America is expected to rise and earn maximum revenue by the end of the forecast period. Europe is the second largest market. The Asia Pacific is expected to be the fastest growing market for stroke disorder and treatment because some countries in this region do have advanced medical facilities.
Key Players
The key players of global stroke disorder and treatment market include AstraZeneca {United Kingdom (UK)}, Bayer Pharma AG (Germany), Daiichi Sankyo (Japan), Novartis AG (Switzerland), and Pfizer {United States of America (US)}.
Posted by at No comments:

2020 Cerebral Vasospasm Market Growth Rate Research Report, Historical Analysis, Opportunities, Business Strategy and Potential of Industry 2023

Global Cerebral Vasospasm Market - Scenario
The advances in medical knowledge are leading to the breakthroughs being achieved in the treatment of cerebral vasospasm. Reports that examine the medical device industry has been presented by Market Research Future, which produces reports on industry verticals that evaluate the market development and opportunities. The market is expected to gain a CAGR of 5.4 % in the upcoming period.
Cerebral vasospasm is most commonly observed in patients who survive subarachnoid hemorrhage. The narrowing of cerebral arteries is termed as cerebral vasospasm. Narrowing of cerebral artery leads to cerebral ischemia and then death. Increasing prevalence of subarachnoid hemorrhage and a rise in the prevalence of traumatic brain injury is the key factor driving the growth of the market.  According to the Centers for Disease Control and Prevention 2017, 30% of the total injury deaths are due to traumatic brain injury in the US. Other factors contributing to the growth of the market are increasing hypertension among the population, rising adoption of smoking, changing lifestyle, growing geriatric population, increasing prevalence of bleeding disorders, rising use of blood thinners and the introduction of technologically advanced treatments.
However, factors such as high cost associated with treatment, risks associated with drugs and medication and a shortage of skilled professionals are expected to hinder the market growth during the forecast period.
Segmentation
Global cerebral vasospasm market is segmented on the basis of type of treatment which includes triple-H therapy, nimodipine and other. On the basis of route of administration the market is segmented into oral, intravenous and intra-arterial and on the basis of end user the market is again segmented into hospitals, clinics and others.
Key Players
  • Headsense Medical Ltd (Israel),
  • Braun Melsungen AG (Germany),
  • Minnetronix, Inc (US),
  • Bristol-Myers Squibb Company (US),
  • Boehringer Ingelheim GmbH (Germany)  
  • Lundbeck A/S (Denmark)
Regional Analysis                                                                                
Geographically, North America has the largest market of cerebral vasospasm. North America cerebral vasospasm market is driven by robust research & development practices along with growing advancements in the field of neurology. Europe has the second largest market of cerebral vasospasm which is followed by Asia Pacific. In Middle East and Africa the market is least due to limited development in the healthcare sector. 
The report of global cerebral vasospasm market by Market Research Future comprises of extensive primary research along with detail analysis of qualitative as well as quantitative aspects by various industry experts and key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the market’s different segments and regions.
Posted by at No comments:

Ventilator-Associated Pneumonia Market Covering Growth Inclinations & Development Strategies until 2025

Market Scenario
According to CDC in 2013, there were 2.8 million traumatic brain injury visits to emergency department and hospitals. The emergency department visits of brain injury patients increased by 47% from 2007. Thus, increasing incidence of TBI drives the growth of the market. Furthermore, increasing geriatric population is likely to fuel the market to grow.  According to the U.S. Census Bureau in 2015, 47.8 million people were 65 years or older, and in 2060, 98.2 million are expected to be 65 years or older.  Such increasing trend in the geriatric population provides favorable backgrounds for the market to grow.
Ventilator-associated pneumonia is a type of lung infection caused to patients who are on ventilators. Ventilator-associated pneumonia is caused mainly due to lung disease, neurologic disease, and trauma to critically ill persons. Diagnosing VAP requires aggressive surveillance combined with the radiographic examination, bedside examination, and microbiologic examinations of respiratory secretions. Growing Intensive Care Unit Admissions due to rising prevalence of respiratory diseases, rising number of ICU beds and high incidence of traumatic injuries provides favorable backgrounds for the market to grow.
However, factors such as expensive diagnostic tests, high ventilator charges, inappropriate reimbursement scenario, risks associated with ventilators are expected to restrict the market growth during the forecast period.
Key players
Some of the key players contributing in the global Ventilator-associated pneumonia market share  are Merck & Co., Inc. (U.S.), Adenium Biotech ApS (Denmark), AstraZeneca (UK), MedImmune (US), Nabriva Therapeutics AG (Austria) and other.
Segmentation
The global Ventilator-associated pneumonia market is segmented on the basis of diagnosis, mode of treatment, and end-user. The Ventilator-associated pneumonia market, by diagnosis categorized into Clinical Examination, Radiological Examination, Microbiological Analysis and others. Microbiological Analysis is further sub-segmented into Blood and pleural fluid cultures, Nonquantitative or semi-quantitative airway sampling and Quantitative cultures of airway specimens. Mode of treatment segment is segmented into Homecare, Hospital care, and others. On the basis of end-user, the market is segmented into Hospitals & Clinics, Research centers, Ambulatory Care Centers and Emergency Medical Services (EMS).      
Regional Market Summary
The Ventilator-associated pneumonia market is dominated by North America owing to the rising geriatric population within the region. The U.S. Census Bureau projected that in 2060, 19.7 million would be of age 85 or older. This influences the growth of this market in this region.
Asia Pacific was projected to be the fastest growing region for the global Ventilator-associated pneumonia market in 2017. The rising geriatric population, increasing healthcare expenditure and growing respiratory disorders in Asia is expected to drive market growth in this region. According to The Asian Development Bank (ADB), the geriatric population in Asia is estimated to reach 923 million by 2050. Thus, this provides favorable backgrounds for the Ventilator-associated pneumonia market to grow.
It is estimated that Europe stood second in the global Ventilator-associated pneumonia market owing to increasing prevalence of lung diseases. According to European respiratory society, more than 50% of deaths are due to lung diseases. Thus, increasing prevalence of lung diseases in this region influences the growth of this market in this region.
The Middle East and Africa holds the least share in the global Ventilator-associated pneumonia market due to the presence of stringent government policies, poor economies, under-developed healthcare infrastructure and low penetration of healthcare services, especially within the African region.
Posted by at No comments:

Enema Bags Market 2020 Covers Global Industry Share, Size, Gross Margin, Future Trends, Demand, Business Insight by Leading Key Players Forecast till 2025

Market Scenario:
Some health problems due to unhealthy eating, drinking in lifestyle may not be fatal but they can a hard time to the body they occur in. One such problem is constipation. A common remedy for constipation is an enema. Apart from constipation, enema provides relief from backaches, fatigue, and headaches. A cleansing enema stimulates the bowels to expel any impacted fecal matter quickly. A remedy helpful for many health problems always grows rapidly as a market. The factors driving the market growth include rising chronic diseases in an aging population with cancer and diabetes coupled with the increasing prevalence of gastrointestinal disorders and growing awareness about enema administration. Home care is advisable to be administered only after the advice of the clinician. Factors that can cause roadblocks to the growth of global enema bags market include the possibility of newer methods of enema treatment and environmental concerns raised from the bags that are made up of silicone, rubber, etc.
Enema is the process of injecting fluid into the bowel via the rectum. This method is used to get relief from various conditions such as constipation, fatigue, headaches, and backaches. It is a process that helps to push out the waste from the rectum. A cleansing enema stimulates the bowels to expel any impacted fecal matter quickly.
The Global Enema Bag Industry Market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global enema bags market is expected to register a CAGR of ~ 10.2 % during the forecast period of 2018–2023.
Enema can be administered at hospitals as well as in home. This technique is also preferred before performing bowel procedures such as radiography and colonoscopy. The most common gastrointestinal condition affecting people nowadays is constipation with the ever-rising prevalence across the globe. Furthermore, the use of enema based products for bowel cleansing is growing extensively.
However, certain disrupting factors that might restrain the growth of enema bags include the possibility of newer methods of enema treatment. Moreover, there might be environmental issues as the bags are made up of silicone, rubber, etc.
Segmentation
The global enema bags market is segmented on the basis of the material type, product type, application, capacity, and end-user.
On the basis of material type, the market is classified into silicone, rubber, and others.
On the basis of administration type, the market is segmented into cleansing enema, carminative enema, retention enema, return-flow enema, and others. Cleansing enema is further segmented into large volume enema, small volume enema, and prepackaged disposable enema. Retention enema is further segmented into oil enema, sedative enema, nutrient enema, anesthetic enema, medicinal enema, and others.
The global enema bags market on the basis of product type is segmented into closed or bottle enema, Higginson enema, bulb enema, bag or fountain travel enema, and others.
On the basis of indication, the market is segmented into constipation, diarrhea, obesity, cancer, and others.
On the basis of preparation, the market is divided into sodium phosphate enemas, coffee enemas, barium enemas, water-soluble contrast enemas, and others. Barium enemas are further segmented into single-column barium enema and double-contrast barium enema.
On the basis of application, the market is segmented as bowel clearing, contrast x-ray, medication administration, and others.
On the basis of capacity, the market is segmented into 100 to 250 ml, 250 to 400 ml, 400 to 600 ml, and others.
On the basis of end-user, the global enema bags market is segmented into hospitals, clinics, research centers, and others.
Geographically, the market has been segmented into America, Europe, Asia Pacific, and the Middle East and Africa. The American enema bags market is further segmented into North America and South America. North America is further classified as the U.S. and Canada.
The European enema bags market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the U.K., Italy, Spain, and the rest of Western Europe. 
The Asia Pacific enema bags market is segmented into Japan, China, India, Republic of Korea, Australia, and the rest of Asia Pacific.
The Middle Eastern and African enema bags market is segmented into the Middle East and Africa.
Top Key Players             
The key players in global enema bags market are Baxter International, Inc. (the USA), B Braun Melsungen AG (Germany),  Cascade Healthcare Products, Inc. (the USA), Coloplast A/S (Denmark), Covidien Private Ltd. (Ireland), Farla Medical Ltd. (UK), Flexicare Medical Limited (UK), Hollister Incorporated (USA), MacoPharma (France), Medline Industries, Inc. (USA), Narang Medical Ltd. (India), Ocean Health Products Ltd. (Singapore), and Qingdao Sinoland International Trade Co., Ltd. (China).
Regional Market Summary
Globally, the American region is the largest market for enema bags owing to the high level of hygiene developed in hospitals and clinics, increasing use of enema-based products at home, and rising demand for enema kits by healthcare providers. As per a study conducted by the Canadian Journal of Gastroenterology, constipation is a common problem among the people in the North American region. Moreover, the study stated that 20% of the North American population suffers from constipation.
Asia Pacific and North America are expected to collectively dominate the enema bags market in terms of volume and value, respectively, due to the increase in awareness towards abdominal diseases and high demand from the pharmaceutical and healthcare industry. The U.S. has the largest market of enema bags in the North American region and countries such as India and China are the highest producers of enema bags in the Asia Pacific region. The factor influencing the growth is the increasing prevalence of chronic diseases such as obesity and diabetes. Currently, the major problem in China and India is diabetes. India had the world’s second-largest population of diabetic patients that was around 69.2 million in 2015 which is expected to increase to 123.5 million by 2040. The number of undiagnosed diabetes is higher in India which was around 36 million in 2015.
The European market is growing due to the increasing prevalence of diarrhea, obesity, and constipation. Increasing cases of enema administration procedures in hospitals are contributing to the progress of the market. The prevalence of diabetes is also found to be increasing in Europe. As per a study published by the World Health Organization, almost 60 million people in the European region have diabetes, and the prevalence tends to be high among people aging 30 years and above.
The Middle East and Africa also shows a steady rise in the market owing to the availability of enema-based products, lack of physical exercise, and increasing cases of constipation.
Posted by at No comments:

Cardiovascular Needle Market Overview with Detailed Analysis, Competitive landscape, Forecast to 2023

Market Insights:
According to the International Diabetes Federation in 2016, it was estimated that 420 million adult population had diabetes, which is increasing at the rate of 8.4% and is expected to reach 625 million by 2040. Furthermore, increasing prevalence of population suffering from cardiovascular diseases, diabetes, and obesity driving the growth of the cardiovascular needles market globally.
The global cardiovascular needles market is growing rapidly owing to its application in various fields such as open heart surgery, cardiac valve procedures, coronary artery bypass graft surgery, heart transplant, and others.
According to the World Health Organization (WHO) in 2015, around 1.6 million deaths were directly caused by diabetes and in 2014, 8.5% of adults aged 18 years and older had diabetes. Thus, rising prevalence of chronic diseases is majorly driving the global cardiovascular market.
According to the World Health Organization (WHO), in 2015, around 17.7 million people died from cardiovascular diseases, which represents 31% of all global deaths. Of these deaths, around 7.4 million were due to coronary heart disease and 6.7 million were due to stroke.
Various factors are adding fuel to the growth of the global cardiovascular needle market, such as unhealthy diet, low physical activities, etc. According to a research, smoking increases the possibility of diabetes; more than 60% of the global population smokes, this has increased the risk of diabetes and contributed to the growth of the market.
Moreover, advancing technology in the medical devices is adding fuel to the growth of the market. Furthermore, increasing government support in the developing countries drive the market growth.
However, increasing use of surgical staples instead of needles and suture can deter the demand for cardiovascular needles.
The global cardiovascular needle market is expected to grow at a CAGR of 7.2% during the forecast period 2017-2023.
Key Players
Some of the key the players in the market are Becton, Dickinson, and Company (US), B. Braun Melsungen AG (Germany), Sheffield Ltd. (UK), CP Medical, Inc. (the US), Ethicon Inc. (US), KLS Martin Group (US), Sklar Surgical Instruments (US), Rumex International Corporation Ltd. (US), Scanlan International Inc. (US), Teleflex Incorporated (US), Medline Industries, Inc. (US), Surgins surgical Ltd. (UK), Surtex Instruments Ltd. (UK), Cardivon Surgical Inc. (China), Symmetry Surgical Inc. (US), Delacroix-Chevalier (France), Wexler Surgical (US), Quality Needles Pvt. Ltd. (India), FSSB surgical needles GmbH (Germany)
Segmentations
The global cardiovascular needle market is segmented on the basis of types, by application, by usage, and by the end user.
On the basis of the type, it is segmented into round bodied needles and cutting needles. Furthermore, round-bodied needles segmented into taper point needles and blunt point needles. Also, cutting needles segmented into conventional cutting needles and reverse cutting needles.  
On the basis of the application, it is segmented into open heart surgery, cardiac valve procedures, coronary artery bypass graft surgery, heart transplant, and others.  
On the basis of the usage, it is segmented into single use and multiple uses.
On the basis of the end user, it is segmented into hospitals, clinics, ambulatory surgical centers, and others.
Regional Analysis
The Americas dominate the global cardiovascular needle market owing to the rising prevalence of diabetes, obesity, and cardiovascular diseases. Furthermore increasing government support for research & development have fuelled the growth of the market in this region. According to the American Heart Association, in 2017, cardiovascular disease listed as the underlying cause of death which is likely to account for nearly 801,000 deaths in the US by the end of this year. It further estimated that about 2,200 Americans die of cardiovascular disease each day.
Europe holds the second position in the global cardiovascular needle market owing to the presence of major players. Although companies within this region are also involved in export to the developing countries which leads the market of Europe.
The Asia Pacific is the fastest growing Cardiovascular Needle market owing to the high presence of a patient with cardiovascular disease. Furthermore, the government of this region is looking forward to better the quality of needles, which increases the demand for cardiovascular needle market in this region.
On the other hand, in the Middle East and Africa hold the least market due to low research and development activities and poor healthcare infrastructure.
Posted by at No comments:

Cardiovascular Needle Market Overview with Detailed Analysis, Competitive landscape, Forecast to 2023

Market Insights:
According to the International Diabetes Federation in 2016, it was estimated that 420 million adult population had diabetes, which is increasing at the rate of 8.4% and is expected to reach 625 million by 2040. Furthermore, increasing prevalence of population suffering from cardiovascular diseases, diabetes, and obesity driving the growth of the cardiovascular needles market globally.
The global cardiovascular needles market is growing rapidly owing to its application in various fields such as open heart surgery, cardiac valve procedures, coronary artery bypass graft surgery, heart transplant, and others.
According to the World Health Organization (WHO) in 2015, around 1.6 million deaths were directly caused by diabetes and in 2014, 8.5% of adults aged 18 years and older had diabetes. Thus, rising prevalence of chronic diseases is majorly driving the global cardiovascular market.
According to the World Health Organization (WHO), in 2015, around 17.7 million people died from cardiovascular diseases, which represents 31% of all global deaths. Of these deaths, around 7.4 million were due to coronary heart disease and 6.7 million were due to stroke.
Various factors are adding fuel to the growth of the global cardiovascular needle market, such as unhealthy diet, low physical activities, etc. According to a research, smoking increases the possibility of diabetes; more than 60% of the global population smokes, this has increased the risk of diabetes and contributed to the growth of the market.
Moreover, advancing technology in the medical devices is adding fuel to the growth of the market. Furthermore, increasing government support in the developing countries drive the market growth.
However, increasing use of surgical staples instead of needles and suture can deter the demand for cardiovascular needles.
The global cardiovascular needle market is expected to grow at a CAGR of 7.2% during the forecast period 2017-2023.
Key Players
Some of the key the players in the market are Becton, Dickinson, and Company (US), B. Braun Melsungen AG (Germany), Sheffield Ltd. (UK), CP Medical, Inc. (the US), Ethicon Inc. (US), KLS Martin Group (US), Sklar Surgical Instruments (US), Rumex International Corporation Ltd. (US), Scanlan International Inc. (US), Teleflex Incorporated (US), Medline Industries, Inc. (US), Surgins surgical Ltd. (UK), Surtex Instruments Ltd. (UK), Cardivon Surgical Inc. (China), Symmetry Surgical Inc. (US), Delacroix-Chevalier (France), Wexler Surgical (US), Quality Needles Pvt. Ltd. (India), FSSB surgical needles GmbH (Germany)
Segmentations
The global cardiovascular needle market is segmented on the basis of types, by application, by usage, and by the end user.
On the basis of the type, it is segmented into round bodied needles and cutting needles. Furthermore, round-bodied needles segmented into taper point needles and blunt point needles. Also, cutting needles segmented into conventional cutting needles and reverse cutting needles.  
On the basis of the application, it is segmented into open heart surgery, cardiac valve procedures, coronary artery bypass graft surgery, heart transplant, and others.  
On the basis of the usage, it is segmented into single use and multiple uses.
On the basis of the end user, it is segmented into hospitals, clinics, ambulatory surgical centers, and others.
Regional Analysis
The Americas dominate the global cardiovascular needle market owing to the rising prevalence of diabetes, obesity, and cardiovascular diseases. Furthermore increasing government support for research & development have fuelled the growth of the market in this region. According to the American Heart Association, in 2017, cardiovascular disease listed as the underlying cause of death which is likely to account for nearly 801,000 deaths in the US by the end of this year. It further estimated that about 2,200 Americans die of cardiovascular disease each day.
Europe holds the second position in the global cardiovascular needle market owing to the presence of major players. Although companies within this region are also involved in export to the developing countries which leads the market of Europe.
The Asia Pacific is the fastest growing Cardiovascular Needle market owing to the high presence of a patient with cardiovascular disease. Furthermore, the government of this region is looking forward to better the quality of needles, which increases the demand for cardiovascular needle market in this region.
On the other hand, in the Middle East and Africa hold the least market due to low research and development activities and poor healthcare infrastructure.
Posted by at No comments:

Spinal Needles Market 2020 Global Trend, Segmentation and Opportunities - Forecast to 2025

Market Scenario
The spinal needles market is expected to register 7.2% CAGR during the forecast period, 2019 to 2025. The market was valued at approximately USD 207.6 million in 2018.
Spinal needles are medical equipment that is generally used for diagnostic or therapeutic purposes. These needles are inserted into the spinal canal for the collection of cerebrospinal fluid (CSF) for diagnostic testing or drug administration for the treatment of diseases. The sample collected is mainly used for diagnosing diseases related to the central nervous system.
Segmentation
The global spinal needles have been segmented based on type, application, end-user, and region. The global market, based on type, has been segmented into atraumatic needles, directional spinal needles, and pencil-point needles. The pencil-point needles segment is expected to be the largest segment, owing to the increasing adoption of the pencil-point needles.
The global market, based on application, has been bifurcated into therapeutic and diagnostic. The therapeutic segment is expected to be largest, in terms of value, due to the increasing prevalence and diagnosis of brain and spinal diseases.      
The global market, based on end-user, has been segmented into hospitals & clinics, diagnostic centers, research laboratories, and others. Hospitals and clinics are the largest end-users of spinal needles market. The hospitals & clinics segment is anticipated to hold a major share of the market during the forecast period due to the growing geriatric population and increasing prevalence of neurodegenerative disorders.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The spinal needles market in the Americas has further been divided into North America and Latin America. In North America, the market is bifurcated into the US and Canada. The European spinal needles market has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, Italy, Spain, the UK, and the rest of Western Europe. The spinal needles market in Asia-Pacific has been segmented into Japan, China, India, South Korea, and Australia. The spinal needles market in the Middle East & Africa has been divided into the Middle East and Africa
Key Players
The key players operating in the global spinal needles market are Boston Scientific Corporation, B. Braun Melsungen AG, Medtronic plc., EXELINT International, Co., Smiths Medical, Stryker Corporation, ARGON MEDICAL, Myco Medical, Cook Medical, and Novo Nordisk A/S. 
Regional Market Summary
The market in the Americas is projected to have a steady growth rate during the forecast period owing to the increasing number of patients with spinal diseases and government initiatives for healthcare reforms. Moreover, there is an increase in the use of these needles by healthcare physicians. According to the American Chiropractic Association, in 2017, one-half of all working Americans admit to having symptoms of back pain every year. Moreover, approximately 17,730 new spinal cord injuries occur each year. Thus, the increasing cases of spinal injuries would ultimately drive the demand for spinal needles in the region.
The market in Europe showed substantial growth during the forecast period. The market growth in this region can be attributed due to the rise in the number of spinal surgeries. According to the World Health Organization (WHO), spinal surgeries increased by 77% in the last five years. Moreover, the rising healthcare expenditure is expected to drive the growth of spinal needles market in this region.
The market in Asia-Pacific is expected to dominate the spinal needles market due to the increasing investment in the development of healthcare infrastructure. Moreover, there is an increase in the number of patients suffering from spinal disease, including spondylitis. Such factors are driving the growth of the spinal needles market in this region.
The market in the Middle East & Africa is expected to grow at a substantial rate due to the increase in the use of surgical treatment for spinal diseases in the region.
Latest Industry News
  • Abacus Finance Group LLC has provided senior debt financing to support Zavation Medical Products LLC’s acquisition of Tampa, Florida-based Pan Medical US Corp, a maker of medical products used in minimally invasive procedures. 22 OCT 2018
  • Two University of Virginia alumni have built a new spine-finding device that is giving the practice of identifying the correct insertion point for epidurals and other forms of spinal anesthesia, a much-needed upgrade. 14 JUNE 2018

Posted by at No comments:
Subscribe to: Posts (Atom)